Skip to content

Canaccord Genuity

Recent events

Recent events tied to this brand in public sources.

Back to profile13 entries

  1. 2021

    Canaccord Genuity completes acquisition of Sawaya Partners

    Canaccord Genuity Group Inc. announced that it had completed its previously announced acquisition of Sawaya Partners, a New York-based M&A advisory firm focused on the consumer sector. Sawaya Partners will operate with Canaccord Genuity branding as “CG/Sawaya Partners.”

  2. 2021

    Canaccord Genuity to acquire Sawaya Partners

    Canaccord Genuity Group announced that it entered into a definitive agreement to acquire Sawaya Partners, an independent M&A advisory firm serving the consumer sector.

  3. 2021

    Canaccord Genuity agrees to acquire Punter Southall Wealth

    Canaccord Genuity Group entered into a share purchase agreement to acquire Punter Southall Group’s wealth business for £164 million in cash. The deal is subject to regulatory approval.

  4. 2021

    NervGen completes C$9.2 million financing

    NervGen Pharma completed its public offering, including the full exercise of the underwriters' over-allotment option, for aggregate gross proceeds of C$9.2 million.

  5. 2021

    Q5id closes $10 million funding round

    Q5id announced that it closed a $10 million private investment funding round led by Canaccord Genuity.

  6. 2021

    GameSquare closes $17 million private placement

    GameSquare closed a previously announced bought-deal private placement that raised $8.5 million, alongside a concurrent non-brokered private placement that raised an additional $8.5 million.

  7. 2021

    Aumento Capital IX completes initial public offering

    Aumento Capital IX Corp. completed its initial public offering of 1,000,000 common shares at $0.50 per share, raising gross proceeds of $500,000.

  8. 2021

    Canaccord Genuity agrees to acquire Adam & Company investment management division

    Canaccord Genuity said it had reached an agreement with NatWest to acquire Adam & Company's £1.7bn investment management division through its UK wealth management arm; the deal was expected to close in September, subject to regulatory approval.

  9. 2021

    QYOU Media completed $11.5 million financing

    QYOU Media closed its previously announced bought deal offering, issuing 41,071,560 units for aggregate gross proceeds of $11,500,037.

  10. 2021

    Aumento Capital VIII completed its initial public offering

    Aumento Capital VIII announced that it completed an initial public offering of 1,000,000 common shares at $0.50 per share, for gross proceeds of $500,000.

  11. 2021

    Neuronetics prices $75 million public stock offering

    Neuronetics announced that it priced an underwritten public offering of 4,840,000 common shares at $15.50 per share. Gross proceeds are expected to be approximately $75 million before offering expenses; closing was expected on or about February 2, subject to customary conditions.

  12. 2021

    MindMed closes CAD $92.1 million offering

    Mind Medicine (MindMed) Inc. closed its bought-deal offering, issuing 20,930,000 units at CAD $4.40 per unit for gross proceeds of approximately CAD $92.1 million.

  13. 2020

    Stem Holdings prices public offering of units

    Stem Holdings announced that it had priced a marketed public offering of units at C$0.55 per unit. The offering was expected to close in January 2021 and remained subject to conditions, including regulatory approvals.